* Focusing on nurturing talent and dedicating to R&D to become a G3 AI powerhouse (Top 3 AI Nations). * Leading the realization of an "AI-driven Basic Society for All" and developing technologies that leverage AI to overcome the crisis in Korea's manufacturing sector. * 50 years ago, South Korea emerged as a scientific and technological powerhouse from the ashes, with KAIST at its core, contributing to the development of scientific and technological talent, innovative technology, national
2025-06-24< Professor Minee Choi of the Department of Brain and Cognitive Sciences (top left). Professor Sonia Gandhi (top right) and Professor Klenerman of the University College London (bottom right) > Parkinson's disease (PD) is a neurodegenerative disorder in which the α-synuclein protein abnormally aggregates within brain cells, causing neuronal damage. Through international collaboration, researchers at KAIST have revealed that RNA editing plays a crucial role in regulating neuroi
2025-05-02KAIST (represented by President Kwang Hyung Lee) announced on January 2nd that it would hold an opening ceremony for the expanded KAIST Center for Contemplative Research (Director Wan Doo Kim) at the Creativity Learning Building on its Daejeon campus on January 3 (Friday). Established in 2018 with the mission of "integrating meditation and science for the happiness and prosperity of humanity," the KAIST Center for Contemplative Research has been expanding its scope of research into the n
2025-01-03KAIST will showcase innovative technologies at the world’s largest technology fair, the Consumer Electronics Show (CES 2025). In addition, KAIST startups VIRNECT Inc., Standard Energy Inc., A2US Inc., and Panmnesia, Inc. won the 2025 CES Innovation Awards. < Image 1. 3D-Graphical Profile of CES 2025 KAIST Exhibition Booth > KAIST (President Kwang-Hyung Lee) announced on the 31st that it will operate a 140㎡ standalone booth at CES Eureka Park, which will be held in Las Vegas,
2024-12-31< (From left) KAIST President Kwang-Hyung Lee and Merck CEO Matthias Heinzel > KAIST (President Kwang-Hyung Lee) signed a Memorandum of Understanding (MOU) with Merck Life Science (CEO Matthias Heinzel) on May 29 to foster innovation and technology creation in advanced biotechnology. Since May of last year, the two institutions have been discussing multidimensional innovation programs and will now focus on industry-academia cooperation to tackle bioindustry challenges with this MOU a
2024-05-30